CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial

Study will advance into expanded patient populations with myelodysplastic syndrome (MDS) and myelofibrosis (MF) SOUTH SAN FRANCISCO, Calif., April 15, 2026: CERo Therapeutics Holdings, Inc., (OTCQB: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it…

Continue Reading

India Pharma 2026 Highlights Shift Towards Innovation in Pharmaceutical Sector

Apr 14 (BNP): The 9th edition of India Pharma 2026 began in New Delhi, bringing together policymakers, industry leaders, and global stakeholders to discuss the future of India’s pharmaceutical industry. The two-day conference, organised by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers in collaboration with FICCI and…

Continue Reading

PFRDA Integrates Healthcare Benefits with NPS Through Swasthya Initiative

The Pension Fund Regulatory and Development Authority (PFRDA) has introduced a new healthcare-linked facility under ‘NPS Swasthya’, aimed at combining retirement savings with medical support for subscribers. Under this initiative, eligible National Pension System (NPS) subscribers can now use a portion of their pension corpus to meet hospitalisation and in-patient…

Continue Reading

AIIMS Delhi Introduces Virtual Reality Facility to Enhance Medical Training

All India Institute of Medical Sciences Delhi has introduced a state-of-the-art virtual reality (VR) training centre aimed at enhancing medical education and clinical training for students. The new facility uses immersive VR technology to simulate real-life medical scenarios, allowing students to practice procedures and decision-making in a controlled, risk-free environment.…

Continue Reading